Fred Goodwin

Affiliations: 
George Washington University, Washington, DC, United States 
Google:
"Fred Goodwin"
Mean distance: 15.57 (cluster 11)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Post RM, Leverich GS, Altshuler LL, et al. (2012) Relationship of prior antidepressant exposure to long-term prospective outcome in bipolar I disorder outpatients. The Journal of Clinical Psychiatry. 73: 924-30
Ghaemi SN, Ostacher MM, El-Mallakh RS, et al. (2010) Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. The Journal of Clinical Psychiatry. 71: 372-80
Goldberg JF, Calabrese JR, Saville BR, et al. (2009) Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo. The Journal of Clinical Psychiatry. 70: 1273-80
Lieberman DZ, Goodwin FK. (2004) Use of olanzapine in the treatment of bipolar I disorder. Expert Review of Neurotherapeutics. 4: 759-67
Ghaemi SN, Hsu DJ, Ko JY, et al. (2004) Bipolar spectrum disorder: a pilot study. Psychopathology. 37: 222-6
Wirz-Justice A, Terman M, Oren DA, et al. (2004) Brightening depression. Science (New York, N.Y.). 303: 467-9
Ghaemi SN, Goodwin FK. (2001) Gabapentin treatment of the non-refractory bipolar spectrum: an open case series. Journal of Affective Disorders. 65: 167-71
Ghaemi SN, Cherry EL, Katzow JA, et al. (2000) Does olanzapine have antidepressant properties? A retrospective preliminary study. Bipolar Disorders. 2: 196-9
Muscettola G, Potter WZ, Pickar D, et al. (1984) Urinary 3-methoxy-4-hydroxyphenylglycol and major affective disorders. A replication and new findings. Archives of General Psychiatry. 41: 337-42
Gold PW, Robertson GL, Ballenger JC, et al. (1983) Neurohypophyseal function in affective illness. Psychopharmacology Bulletin. 19: 426-31
See more...